These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9153103)

  • 1. Reversible uremic deafness: is it correlated with the degree of anemia?
    Shaheen FA; Mansuri NA; al-Shaikh AM; Sheikh IA; Huraib SO; al-Khader AA; Zazgornik J
    Ann Otol Rhinol Laryngol; 1997 May; 106(5):391-3. PubMed ID: 9153103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
    Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
    Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients.
    Kuriyama S; Tomonari H; Yoshida H; Hashimoto T; Kawaguchi Y; Sakai O
    Nephron; 1997; 77(2):176-85. PubMed ID: 9346384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease.
    Chen HH; Tarng DC; Lee KF; Wu CY; Chen YC
    J Nephrol; 2008; 21(4):543-9. PubMed ID: 18651544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure.
    Di Iorio BR; Minutolo R; De Nicola L; Bellizzi V; Catapano F; Iodice C; Rubino R; Conte G
    Kidney Int; 2003 Nov; 64(5):1822-8. PubMed ID: 14531817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of erythropoietin for treatment of anemia in chronic kidney failure- ESRD patients.
    Srinivasan R; Fredy IC; Chandrashekar S; Saravanan J; Mohanta GP; Manna PK
    Biomed Pharmacother; 2016 Aug; 82():44-8. PubMed ID: 27470337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of erythropoietin treatment on physical exercise capacity and on renal function in predialytic uremic patients.
    Clyne N; Jogestrand T
    Nephron; 1992; 60(4):390-6. PubMed ID: 1584314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure.
    Ataka K; Maruyama H; Neichi T; Miyazaki J; Gejyo F
    Am J Nephrol; 2003; 23(5):315-23. PubMed ID: 12915775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
    Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
    Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
    Sinnassamy P; Andre JL; Treize G; Leroy B
    Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of anemia with recombinant human erythropoietin and the bone marrow response in uremic patients undergoing periodic hemodialysis].
    García Martín F; Carrascosa Vallejo T; Martín Escobar E; Val Begueria J; Martín Hernández R; de Arriba G; Teno C; Salvatierra J
    Rev Clin Esp; 1990 May; 186(9):419-22. PubMed ID: 2247677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
    Icardi A; Paoletti E; Molinelli G
    Adv Perit Dial; 1990; 6():292-5. PubMed ID: 1982830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: effect of long-term therapy with erythropoietin.
    Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
    Kidney Int; 2005 Jul; 68(1):246-55. PubMed ID: 15954914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.
    Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H
    Am J Nephrol; 2006; 26(3):276-80. PubMed ID: 16772708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of hearing organ ability in high-frequency auditory in patients suffering from chronic renal failure treated by haemodialysis and human recombinant erythropoietin (rhPEO)].
    Markowski J; Gierek T; Wiecek A; Klimek D; Chudek J
    Otolaryngol Pol; 2002; 56(5):589-96. PubMed ID: 12523169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].
    Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC
    Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.